Sign Out
Hepatobiliary Disorders: hepatitis, jaundice, fatal and non-fatal hepatic failure.
Musculoskeletal Disorders: arthralgia, rare reports of immune-mediated necrotizing myopathy associated with statin use.
Nervous System Disorders: peripheral neuropathy, rare postmarketing reports of cognitive impairment (e.g., memory loss, forgetfulness, amnesia, memory impairment, and confusion) associated with the use of all statins. The reports are generally nonserious, and reversible upon discontinuation of treatment.
Psychiatric Disorders: depression, sleep disorders (including insomnia and nightmares).
Reproductive System and Breast Disorders: gynecomastia.
Respiratory Disorders: interstitial lung disease.
Skin and Subcutaneous Tissue Disorders: drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption.
View ADR Reporting Link
